Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Mads Gyrd-Hansen, from the Ludwig Institute for Cancer Research at the University of Oxford has received a prestigious Sapere Aude DFF-Starting Grant from the Danish Council for Independent Research, to investigate the role of ubiquitin in controlling innate immune signalling and inflammation.

Mads Gyrd-HansenThe objective of the Sapere Aude Starting Grant is to give the very best researchers who have achieved outstanding results in their field an opportunity to develop and strengthen their research ideas. 

Dr Gyrd-Hansen said: “I am honoured to have received such a prestigious grant. It will enable me to initiate a long-term and ambitious project to answer key questions about how communication in the immune system works.”

Dr Gyrd-Hansen attended an awards ceremony for the grant in Denmark on 6th February 2014 was awarded his diploma by the Danish Minister for Higher Education and Science.

Mads Gyrd-HansenImages:

Left: Dr Gyrd-Hansen with his diploma

Right: Dr Gyrd-Hansen front row, 2nd on the right, next to the Head of the Board of Directors and the Danish Minister for Higher Education and Science, front row, 4th on the left

Dr Mads Gyrd-Hansen webpage

Ludwig Institute for Cancer Research

Sapere Aude DFF-Starting Grant